We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Epigallocatechin-3-gallate suppresses TNF-α -induced production of MMP-1 and -3 in rheumatoid arthritis synovial fibroblasts.
- Authors
Hee-Jin Yun; Wan-Hee Yoo; Myung-Kwan Han; Young-Rae Lee; Jong-Suk Kim; Sang-Il Lee
- Abstract
Rheumatoid arthritis (RA) synovial fibroblasts produce matrix metaloproteinases (MMPs), which destruct cartilage and bone in RA joint. Tumor necrosis factor-α (TNF-α) is one of the most important mediator leading to MMP production in RA synovial fibroblasts. Here we show that epigallocatechin-3-Gallate (EGCG) suppresses TNF-α-induced production of MMP-1 and MMP-3 in RA synovial fibroblasts, which was accompanied by inhibition of mitogen activated protein kinase (MAPK) and activator protein-1 (AP-1) pathways. EGCG treatment resulted in dose-dependent inhibition of TNF-α-induced production of MMP-1 and MMP-3 at the protein and mRNA levels in RA synovial fibroblast. EGCG treatment also inhibited TNF-α-induced phosphorylation of MAPKs, such as ERK1/2, p38, JNK. Electrophoretic mobility shift assay revealed that EGCG inhibits binding of AP-1 proteins to its response elements in synovial fibroblast treated. Thus, EGCG may play a role in regulating inflammation and bone destruction in RA patients.
- Subjects
MEDICAL sciences; RHEUMATOID arthritis; PROTEIN kinases; FIBROBLASTS; TUMOR necrosis factors; PHOSPHORYLATION
- Publication
Rheumatology International, 2008, Vol 29, Issue 1, p23
- ISSN
0172-8172
- Publication type
Article
- DOI
10.1007/s00296-008-0597-5